145 related articles for article (PubMed ID: 21311411)
21. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.
Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR
Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214
[TBL] [Abstract][Full Text] [Related]
22. Algorithms outperform metabolite tests in predicting response of patients with inflammatory bowel disease to thiopurines.
Waljee AK; Joyce JC; Wang S; Saxena A; Hart M; Zhu J; Higgins PD
Clin Gastroenterol Hepatol; 2010 Feb; 8(2):143-50. PubMed ID: 19835986
[TBL] [Abstract][Full Text] [Related]
23. Novel assay to improve therapeutic drug monitoring of thiopurines in inflammatory bowel disease.
Vikingsson S; Andersson D; Almer S; Peterson C; Hindorf U
J Crohns Colitis; 2014 Dec; 8(12):1702-9. PubMed ID: 25239576
[TBL] [Abstract][Full Text] [Related]
24. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
Banerjee S; Bishop WP
J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
[TBL] [Abstract][Full Text] [Related]
25. Assessment of thiopurine methyltransferase and metabolite formation during thiopurine therapy: results from a large Swedish patient population.
Hindorf U; Peterson C; Almer S
Ther Drug Monit; 2004 Dec; 26(6):673-8. PubMed ID: 15570193
[TBL] [Abstract][Full Text] [Related]
26. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.
Hindorf U; Lyrenäs E; Nilsson A; Schmiegelow K
Scand J Gastroenterol; 2004 Nov; 39(11):1105-12. PubMed ID: 15545169
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases.
Dewit O
Acta Gastroenterol Belg; 2010; 73(3):331-5. PubMed ID: 21086934
[TBL] [Abstract][Full Text] [Related]
28. Routinely Established Skewed Thiopurine Metabolism Leads to a Strikingly High Rate of Early Therapeutic Failure in Patients With Inflammatory Bowel Disease.
Kreijne JE; Seinen ML; Wilhelm AJ; Bouma G; Mulder CJ; van Bodegraven AA; de Boer NK
Ther Drug Monit; 2015 Dec; 37(6):797-804. PubMed ID: 25853923
[TBL] [Abstract][Full Text] [Related]
29. Red Blood cell IMPDH activity in adults and children with or without azathioprine: Relationship between thiopurine metabolites, ITPA and TPMT activities.
Citterio-Quentin A; El Mahmoudi A; Perret T; Conway A; Ryan A; Beringer A; Lachaux A; Boulieu R
Basic Clin Pharmacol Toxicol; 2019 May; 124(5):600-606. PubMed ID: 30451390
[TBL] [Abstract][Full Text] [Related]
30. Thiopurine methyltransferase (TPMT) activity and adverse effects of azathioprine in inflammatory bowel disease: long-term follow-up study of 394 patients.
Gisbert JP; Niño P; Rodrigo L; Cara C; Guijarro LG
Am J Gastroenterol; 2006 Dec; 101(12):2769-76. PubMed ID: 17026564
[TBL] [Abstract][Full Text] [Related]
31. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study.
Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA
J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929
[TBL] [Abstract][Full Text] [Related]
32. S-adenosylmethionine regulates thiopurine methyltransferase activity and decreases 6-mercaptopurine cytotoxicity in MOLT lymphoblasts.
Milek M; Karas Kuzelicki N; Smid A; Mlinaric-Rascan I
Biochem Pharmacol; 2009 Jun; 77(12):1845-53. PubMed ID: 19428339
[TBL] [Abstract][Full Text] [Related]
33. Differential role of thiopurine methyltransferase in the cytotoxic effects of 6-mercaptopurine and 6-thioguanine on human leukemia cells.
Karim H; Ghalali A; Lafolie P; Vitols S; Fotoohi AK
Biochem Biophys Res Commun; 2013 Jul; 437(2):280-6. PubMed ID: 23811272
[TBL] [Abstract][Full Text] [Related]
34. Monitoring of thiopurine metabolites in patients with inflammatory bowel disease-what is actually measured?
Vikingsson S; Carlsson B; Almer SH; Peterson C
Ther Drug Monit; 2009 Jun; 31(3):345-50. PubMed ID: 19363461
[TBL] [Abstract][Full Text] [Related]
35. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
[TBL] [Abstract][Full Text] [Related]
36. Hypoxanthine guanine phosphoribosyltransferase activity is related to 6-thioguanine nucleotide concentrations and thiopurine-induced leukopenia in the treatment of inflammatory bowel disease.
Ding L; Zhang FB; Liu H; Gao X; Bi HC; Wang XD; Chen BL; Zhang Y; Zhao LZ; Zhong GP; Hu PJ; Chen MH; Huang M
Inflamm Bowel Dis; 2012 Jan; 18(1):63-73. PubMed ID: 21381155
[TBL] [Abstract][Full Text] [Related]
37. Relationship between azathioprine dosage and thiopurine metabolites in pediatric IBD patients: identification of covariables using multilevel analysis.
Nguyen TV; Vu DH; Nguyen TM; Lachaux A; Boulieu R
Ther Drug Monit; 2013 Apr; 35(2):251-7. PubMed ID: 23503453
[TBL] [Abstract][Full Text] [Related]
38. Monitoring thiopurine metabolites in korean pediatric patients with inflammatory bowel disease.
Kim MJ; Lee SY; Choe YH
Yonsei Med J; 2014 Sep; 55(5):1289-96. PubMed ID: 25048487
[TBL] [Abstract][Full Text] [Related]
39. Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease.
Kennedy NA; Asser TL; Mountifield RE; Doogue MP; Andrews JM; Bampton PA
Intern Med J; 2013 Mar; 43(3):278-86. PubMed ID: 22946880
[TBL] [Abstract][Full Text] [Related]
40. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
